IT1313551B1 - Composizioni farmaceutiche disperdibili spontaneamente checontengono un antagonista della sostanza p costituito dalla - Google Patents

Composizioni farmaceutiche disperdibili spontaneamente checontengono un antagonista della sostanza p costituito dalla

Info

Publication number: IT1313551B1
Authority: IT; Italy
Prior art keywords: spontaneously; antagonist; constituted; substance; contain
Prior art date: 1998-05-26

Application number

IT1999MI001164A

Other languages

English (en)

Inventor

Steffen Lang

Kurt Liechti

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-26

Filing date

1999-05-26

Publication date

2002-09-09

1998-05-26 Priority claimed from GBGB9811200.6A external-priority patent/GB9811200D0/en

1998-08-19 Priority claimed from GBGB9818105.0A external-priority patent/GB9818105D0/en

1999-05-26 Application filed by Novartis Ag filed Critical Novartis Ag

2000-11-26 Publication of ITMI991164A1 publication Critical patent/ITMI991164A1/it

2002-09-09 Application granted granted Critical

2002-09-09 Publication of IT1313551B1 publication Critical patent/IT1313551B1/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Biophysics (AREA)
Dispersion Chemistry (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IT1999MI001164A 1998-05-26 1999-05-26 Composizioni farmaceutiche disperdibili spontaneamente checontengono un antagonista della sostanza p costituito dalla IT1313551B1 (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9811200.6A GB9811200D0 (en)	1998-05-26	1998-05-26	Organic compounds
GBGB9818105.0A GB9818105D0 (en)	1998-08-19	1998-08-19	Organic compounds

Publications (2)

Publication Number	Publication Date
ITMI991164A1 ITMI991164A1 (it)	2000-11-26
IT1313551B1 true IT1313551B1 (it)	2002-09-09

Family

ID=26313736

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT1999MI001164A IT1313551B1 (it)	1998-05-26	1999-05-26	Composizioni farmaceutiche disperdibili spontaneamente checontengono un antagonista della sostanza p costituito dalla

Country Status (31)

Country	Link
US (2)	US20020156099A1 (it)
EP (1)	EP1082119B1 (it)
JP (1)	JP4083985B2 (it)
KR (1)	KR20010043669A (it)
CN (1)	CN1270714C (it)
AR (1)	AR018376A1 (it)
AT (1)	ATE257380T1 (it)
AU (1)	AU755134B2 (it)
BE (1)	BE1012143A5 (it)
BR (1)	BR9910696A (it)
CA (1)	CA2333154C (it)
DE (2)	DE19983247T1 (it)
DK (1)	DK1082119T3 (it)
ES (1)	ES2214859T3 (it)
FR (1)	FR2779145B1 (it)
GB (1)	GB2353473A (it)
HK (1)	HK1035137A1 (it)
HU (1)	HUP0102202A3 (it)
ID (1)	ID27096A (it)
IL (1)	IL139501A0 (it)
IT (1)	IT1313551B1 (it)
NO (1)	NO20005920L (it)
NZ (1)	NZ508325A (it)
PE (1)	PE20000537A1 (it)
PL (1)	PL344245A1 (it)
PT (1)	PT1082119E (it)
RU (1)	RU2240121C2 (it)
SK (1)	SK17752000A3 (it)
TR (1)	TR200003502T2 (it)
TW (1)	TW537894B (it)
WO (1)	WO1999061025A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW537894B (en)	1998-05-26	2003-06-21	Novartis Ag	A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
US7202282B2 (en) *	2002-04-22	2007-04-10	University Of Florida	Microemulsions for selective molecular separation
GB0220953D0 (en) *	2002-09-10	2002-10-23	Novartis Ag	Organic compounds
US7842791B2 (en)	2002-12-19	2010-11-30	Nancy Jean Britten	Dispersible pharmaceutical compositions
FR2934953B1 (fr)	2008-08-14	2011-01-21	Commissariat Energie Atomique	Nanoemulsions de nanocristaux
FR2934954B1 (fr)	2008-08-14	2011-07-22	Commissariat Energie Atomique	Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr)	2008-08-14	2011-07-08	Commissariat Energie Atomique	Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2935001B1 (fr) *	2008-08-14	2011-12-30	Commissariat Energie Atomique	Emulsion fluorescente
CN105209011B (zh) *	2012-12-31	2019-06-25	Jrx生物技术有限公司	液体的局部药用的纳米乳液制剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3305689A1 (de)	1983-02-18	1984-08-23	Mack Chem Pharm	Pharmazeutische zubereitung mit retardwirkung
US5342625A (en) *	1988-09-16	1994-08-30	Sandoz Ltd.	Pharmaceutical compositions comprising cyclosporins
MY110227A (en)	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
DE4220616C2 (de)	1992-06-24	1994-12-22	Byk Gulden Lomberg Chem Fab	Dexniguldipin zur intravenösen Verabreichung
ES2168271T3 (es)	1992-09-25	2002-06-16	Novartis Ag	Composiciones farmaceuticas que contienen ciclosporinas.
GB2278780B (en) *	1993-05-27	1998-10-14	Sandoz Ltd	Macrolide formulations
EP0788346B9 (en) *	1994-03-18	2007-02-14	Supernus Pharmaceuticals, Inc.	Emulsified drug delivery systems
TW397825B (en) *	1994-10-14	2000-07-11	Novartis Ag	Aroyl-piperidine derivatives
GB2308545B (en)	1994-10-26	1999-06-02	Novartis Ag	Pharmaceutical microemulsion preconcentrates
FR2728165A1 (fr) *	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr)	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
KR19980703354A (ko) *	1995-03-27	1998-10-15	나카토미히로타카	피페리딘 유도체
NZ280689A (en)	1995-12-15	1997-08-22	Bernard Charles Sherma Sherman	Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
GB9601120D0 (en)	1996-01-19	1996-03-20	Sandoz Ltd	Organic compounds
AU2898297A (en)	1996-05-24	1998-01-05	Novartis Ag	Use of substance p antagonists for treating social phobia
TW537894B (en)	1998-05-26	2003-06-21	Novartis Ag	A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist

1999
- 1999-05-24 TW TW088108449A patent/TW537894B/zh not_active IP Right Cessation
- 1999-05-24 AR ARP990102454A patent/AR018376A1/es not_active Application Discontinuation
- 1999-05-25 PE PE1999000436A patent/PE20000537A1/es not_active Application Discontinuation
- 1999-05-25 BE BE9900364A patent/BE1012143A5/fr not_active IP Right Cessation
- 1999-05-26 BR BR9910696-5A patent/BR9910696A/pt not_active Application Discontinuation
- 1999-05-26 HU HU0102202A patent/HUP0102202A3/hu unknown
- 1999-05-26 EP EP99927760A patent/EP1082119B1/en not_active Expired - Lifetime
- 1999-05-26 SK SK1775-2000A patent/SK17752000A3/sk unknown
- 1999-05-26 PL PL99344245A patent/PL344245A1/xx unknown
- 1999-05-26 KR KR1020007012871A patent/KR20010043669A/ko not_active Application Discontinuation
- 1999-05-26 GB GB0028506A patent/GB2353473A/en not_active Withdrawn
- 1999-05-26 CN CNB998066036A patent/CN1270714C/zh not_active Expired - Fee Related
- 1999-05-26 AU AU45008/99A patent/AU755134B2/en not_active Ceased
- 1999-05-26 TR TR2000/03502T patent/TR200003502T2/xx unknown
- 1999-05-26 IT IT1999MI001164A patent/IT1313551B1/it active
- 1999-05-26 ID IDW20002316A patent/ID27096A/id unknown
- 1999-05-26 AT AT99927760T patent/ATE257380T1/de not_active IP Right Cessation
- 1999-05-26 CA CA002333154A patent/CA2333154C/en not_active Expired - Fee Related
- 1999-05-26 IL IL13950199A patent/IL139501A0/xx unknown
- 1999-05-26 FR FR9906629A patent/FR2779145B1/fr not_active Expired - Fee Related
- 1999-05-26 WO PCT/EP1999/003623 patent/WO1999061025A1/en not_active Application Discontinuation
- 1999-05-26 ES ES99927760T patent/ES2214859T3/es not_active Expired - Lifetime
- 1999-05-26 DE DE19983247T patent/DE19983247T1/de not_active Withdrawn
- 1999-05-26 DK DK99927760T patent/DK1082119T3/da active
- 1999-05-26 NZ NZ508325A patent/NZ508325A/xx unknown
- 1999-05-26 DE DE69914077T patent/DE69914077T2/de not_active Expired - Lifetime
- 1999-05-26 JP JP2000550485A patent/JP4083985B2/ja not_active Expired - Fee Related
- 1999-05-26 PT PT99927760T patent/PT1082119E/pt unknown
- 1999-05-26 RU RU2000133308/15A patent/RU2240121C2/ru not_active IP Right Cessation
2000
- 2000-11-23 NO NO20005920A patent/NO20005920L/no not_active Application Discontinuation
2001
- 2001-08-16 HK HK01105781A patent/HK1035137A1/xx not_active IP Right Cessation
2002
- 2002-04-10 US US10/119,549 patent/US20020156099A1/en not_active Abandoned
2003
- 2003-03-04 US US10/379,345 patent/US6949257B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6949257B2 (en)	2005-09-27
HK1035137A1 (en)	2001-11-16
KR20010043669A (ko)	2001-05-25
ITMI991164A1 (it)	2000-11-26
TR200003502T2 (tr)	2001-04-20
GB0028506D0 (en)	2001-01-10
JP2002516280A (ja)	2002-06-04
FR2779145B1 (fr)	2004-07-30
CA2333154C (en)	2008-07-08
AR018376A1 (es)	2001-11-14
DE69914077T2 (de)	2004-06-09
JP4083985B2 (ja)	2008-04-30
NO20005920D0 (no)	2000-11-23
FR2779145A1 (fr)	1999-12-03
HUP0102202A3 (en)	2003-01-28
BR9910696A (pt)	2001-01-30
DE69914077D1 (de)	2004-02-12
RU2240121C2 (ru)	2004-11-20
CN1303285A (zh)	2001-07-11
PE20000537A1 (es)	2000-07-10
DE19983247T1 (de)	2001-05-31
DK1082119T3 (da)	2004-04-13
IL139501A0 (en)	2001-11-25
ES2214859T3 (es)	2004-09-16
EP1082119A1 (en)	2001-03-14
CA2333154A1 (en)	1999-12-02
US20030152626A1 (en)	2003-08-14
NZ508325A (en)	2003-06-30
AU755134B2 (en)	2002-12-05
CN1270714C (zh)	2006-08-23
WO1999061025A1 (en)	1999-12-02
EP1082119B1 (en)	2004-01-07
ATE257380T1 (de)	2004-01-15
BE1012143A5 (fr)	2000-05-02
NO20005920L (no)	2001-01-25
GB2353473A (en)	2001-02-28
ID27096A (id)	2001-03-01
PL344245A1 (en)	2001-10-08
HUP0102202A2 (hu)	2001-11-28
TW537894B (en)	2003-06-21
SK17752000A3 (sk)	2001-05-10
AU4500899A (en)	1999-12-13
US20020156099A1 (en)	2002-10-24
PT1082119E (pt)	2004-05-31

Publication	Publication Date	Title
ATE296619T1 (de)	2005-06-15	Feste orale dosierungsform von simethicon
FR2795324B1 (fr)	2002-05-17	Compositions pharmaceutiques stabilisees
PT996430E (pt)	2003-03-31	Composicoes de analogos nucleotidicos
IS2325B (is)	2007-12-15	Örgerðar samsetningar epleróns
EA199900373A2 (ru)	1999-12-29	Фармацевтические композиции
KR970702720A (ko)	1997-06-10	항간질 약물에 효과적인 제형(Effectice Dosage Form for Antiepileptic Drugs)
DE69924999D1 (de)	2005-06-02	Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DK1275387T3 (da)	2006-08-28	Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK1393721T3 (da)	2009-03-30	Doseringsform af pulveragglomerater
NO20020464D0 (no)	2002-01-29	Flerkomponent-farmasöytisk doseringsform
NO331819B1 (no)	2012-04-10	Hurtigdispergerende fast terapeutisk doseringsform
IS2184B (is)	2006-12-15	Lyfjaform með áfangalosun til inntöku um munn
DK1093370T3 (da)	2006-05-22	Farmaceutisk præparat til behandling af diabetes
DK1021194T3 (da)	2003-09-01	Ny forbedret formulering til behandling af osteoporose
ID23872A (id)	2000-05-25	Komposisi farmasi padat yang mengandung turunan benzofuran
NO992692L (no)	1999-12-06	Nefadozon doseringsform
ATE259590T1 (de)	2004-03-15	Pour-on formulierungen
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
DK0866069T3 (da)	2003-03-24	Fremstilling af ascorbylmonophosphater
ATE370728T1 (de)	2007-09-15	Antagonisten des gardos-kanals
ATE273697T1 (de)	2004-09-15	Pharmazeutische levothyroxinzubereitung
IT1313551B1 (it)	2002-09-09	Composizioni farmaceutiche disperdibili spontaneamente checontengono un antagonista della sostanza p costituito dalla
DE69805334D1 (de)	2002-06-13	Derivate des vitamin e
SE9801494D0 (sv)	1998-04-28	Novel use
EE04439B1 (et)	2005-02-15	5HT1 antagonistid antidepressantraviks